NICOLE L CHEKANOWSKY

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant HARRISVILLE, PA NPI 1194944181

General Payments — all program years on this page

$760.11

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 40
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $385.86 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $385.8620

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $223.1611
GlaxoSmithKline, LLC. $104.206
PFIZER INC. $37.102
Boehringer Ingelheim Pharmaceuticals, Inc. $21.401

By program year

Program yearAmountRecords
2022 $39.302
2023 $334.9518
2024 $385.8620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100254208 Novo Nordisk Inc $21.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100292693 Novo Nordisk Inc $17.27 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100356750 Novo Nordisk Inc $17.61 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100460780 Novo Nordisk Inc $8.67 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100505035 Novo Nordisk Inc $24.02 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100509249 Novo Nordisk Inc $23.52 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100514671 Novo Nordisk Inc $21.88 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100544148 Novo Nordisk Inc $23.22 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100589019 Novo Nordisk Inc $23.78 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100610952 Novo Nordisk Inc $17.29 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100621416 Novo Nordisk Inc $24.02 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115810010 GlaxoSmithKline, LLC. $15.05 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116117334 GlaxoSmithKline, LLC. $19.84 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116272000 GlaxoSmithKline, LLC. $17.89 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116644216 GlaxoSmithKline, LLC. $13.65 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116660423 GlaxoSmithKline, LLC. $15.96 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116682515 GlaxoSmithKline, LLC. $21.81 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117912788 Boehringer Ingelheim Pharmaceuticals, Inc. $21.40 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132064648 PFIZER INC. $17.44 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132064786 PFIZER INC. $19.66 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.